English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Imatib Cipla 100 400 mg
850 INR
Product Details:
- Grade Pharmaceutical
- Purity 99%
- Formulations Type General Drugs
- Formulations Form Tablets
- Gender/Age Group Infants, Adult, Women, Suitable For All Ages
- Dosage Guidelines 400 mg
- Storage Instructions Dry Place
- Supply Ability : 100 Box Box Per Day
- Click to view more
X
Price And Quantity
- 10 Box
- 850 INR
Product Specifications
- Tablets
- General Drugs
- 400 mg
- Dry Place
- Infants, Adult, Women, Suitable For All Ages
- Pharmaceutical
- 99%
Trade Information
- Cash Advance (CA), Cash in Advance (CID), Cheque, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union
- 100 Box Box Per Day
- 1 Week
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
After creating a niche in the industry, we are highly praised for exporting and supplying Imatib (Cipla) 100 & 400 Mg. Principally, Imatinib is present as small molecule kinase inhibitor that is intended to be used for management of certain types of cancer. Depending on the unmatched qualities, this range is widely recommended for treating chronic myelogenous leukemia, gastrointestinal stromal tumors and other malignancies. Mode of action of Imatib (Cipla) 100 & 400 Mg shows that is belongs to a new category of drugs, which acts by inhibiting tyrosine kinase enzymes, in turn inhibiting rapidly dividing cells.
Benefits:
- Perfect formulation
- High purity level
- Optimum effectiveness
Enter Buying Requirement Details
Other Products in 'Generic Pharmaceutical Drugs' category
- A/14 Bonanza Industrial Estate, Off Western Express Highway, Kandivali East, Mumbai - 400101, Maharashtra, India
- Phone : 08037302156
- Fax : 91-22-28875432
-
Send Inquiry
Send InquiryMobile : 09821672805
Send Inquiry
Send SMS
- Mr. Piyansh Mantry (Proprietor)
- Mobile : 08037302156
|
 |
3S CORPORATION
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |